Bosutinib hydrate (SKI-606 hydrate) is an orally active and potent dual kinase inhibitor of BCR-ABL and Src tyrosine kinases for the study of Philadelphia Chromosome Positive Chronic Granulocytic Leukemia.
Molecular Weight:
548.46
Purity:
99.87%
CAS Number:
[918639-08-4]
Formula:
C26H31Cl2N5O4
Target:
Bcr-Abl|||Src
T63875
* VAT and and shipping costs not included. Errors and price changes excepted